Literature DB >> 20944122

Caveolin-1 and doxorubicin-induced P-glycoprotein modulate plasma cholesterol membrane accessibility in erythrolymphoblastic cell line.

Miaojun Zhu1, Laurence LE Moyec, Anna Starzec, Verene Stierle, Carole Marbeuf-Gueye.   

Abstract

UNLABELLED: AIM/
BACKGROUND: Various interactions between Caveolae membrane domains, multidrug resistance transporter P-glycoprotein (P-gp) and cholesterol have been suggested. We tested the assumption that anthracycline-induced P-gp and Caveolin-1 have correlated effects on cholesterol distribution in plasma membrane.
MATERIALS AND METHODS: The present study was performed in four lymphoblastic K562 cell lines expressing none (KS), one (Cav and KR cells) or both P-gp and caveolin-1 proteins (CavKR cells).
RESULTS: The CavKR cell line exhibits a significantly higher free cholesterol content than the other cell lines. Cholesterol distribution at the outer leaflet was distinct from the total cellular cholesterol by its accessibility to cholesterol oxidase (COase). When cells were ATP-deprived, cholesterol accessibility to oxidation was significantly delayed in CavKR cells. Caveolin-1 or P-gp expression did not induce detectable changes in membrane cholesterol accessibility to COase.
CONCLUSION: Combination of functional P-gp, caveolae presence and lasting effect of anthracycline treatment appear determinant in free membrane cholesterol homeostasis and likely modulate cholesterol membrane order.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944122

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier.

Authors:  Do-Geun Kim; Margaret S Bynoe
Journal:  J Clin Invest       Date:  2016-04-04       Impact factor: 14.808

2.  The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells.

Authors:  L Mi; F Zhu; X Yang; J Lu; Y Zheng; Q Zhao; X Wen; A Lu; M Wang; M Zheng; J Ji; J Sun
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.